Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”
Currently, there is no evidence that unbound isavuconazole concentrations are a better predictor of treatment response than total concentrations. [...]clinical implementation of monitoring unbound isavuconazole concentrations in routine clinical practice is difficult to justify. While isavuconazole...
Saved in:
| Published in: | Clinical pharmacokinetics Vol. 63; no. 5; pp. 731 - 733 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Cham
Springer International Publishing
01.05.2024
Springer Nature B.V |
| Subjects: | |
| ISSN: | 0312-5963, 1179-1926, 1179-1926 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Currently, there is no evidence that unbound isavuconazole concentrations are a better predictor of treatment response than total concentrations. [...]clinical implementation of monitoring unbound isavuconazole concentrations in routine clinical practice is difficult to justify. While isavuconazole is highly protein bound, it has a low intrinsic clearance; therefore, changes in the fraction unbound are unlikely to impact its pharmacokinetics (specifically clearance). [...]we propose that the importance of measuring unbound isavuconazole concentrations, as a better predictor of treatment response, should be established before implementation of routine monitoring of free concentrations. [...]a better understanding of isavuconazole pharmacokinetics/pharmacodynamics and its unbound drug concentrations will have practical implications regarding how we perform therapeutic drug monitoring. |
|---|---|
| AbstractList | Currently, there is no evidence that unbound isavuconazole concentrations are a better predictor of treatment response than total concentrations. [...]clinical implementation of monitoring unbound isavuconazole concentrations in routine clinical practice is difficult to justify. While isavuconazole is highly protein bound, it has a low intrinsic clearance; therefore, changes in the fraction unbound are unlikely to impact its pharmacokinetics (specifically clearance). [...]we propose that the importance of measuring unbound isavuconazole concentrations, as a better predictor of treatment response, should be established before implementation of routine monitoring of free concentrations. [...]a better understanding of isavuconazole pharmacokinetics/pharmacodynamics and its unbound drug concentrations will have practical implications regarding how we perform therapeutic drug monitoring. |
| Author | Alffenaar, Jan-Willem C. Stocker, Sophie L. Kong, Leping |
| Author_xml | – sequence: 1 givenname: Leping orcidid: 0009-0008-6612-044X surname: Kong fullname: Kong, Leping organization: Faculty of Medicine and Health, School of Pharmacy, University of Sydney – sequence: 2 givenname: Jan-Willem C. orcidid: 0000-0001-6703-0288 surname: Alffenaar fullname: Alffenaar, Jan-Willem C. organization: Faculty of Medicine and Health, School of Pharmacy, University of Sydney, The University of Sydney Infectious Disease Institute, Department of Pharmacy, Westmead Hospital – sequence: 3 givenname: Sophie L. orcidid: 0000-0002-2114-587X surname: Stocker fullname: Stocker, Sophie L. email: sophie.stocker@sydney.edu.au organization: Faculty of Medicine and Health, School of Pharmacy, University of Sydney, The University of Sydney Infectious Disease Institute, Department of Pharmacy, Westmead Hospital, Department of Clinical Pharmacology & Toxicology, St. Vincent’s Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38573478$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ks9uEzEQhxdURNPCC3BAlrhwWWqv929vYaE0UiUiSLmuZr2T1K3XXmxvpXDqg8DL9UlwkgZED5ws29_MfLZ-R9GBNhqj6BWj7xilxYlLaZInMU3SmDKeFXH6NJowVlQxq5L8IJpQzpI4q3J-GB05d00pLRNKn0eHvMwKnhbl5ElRm75H7YnR5P7u59wMowIvw25-BbYHYW6kRi-FI2ZJFsaDIqA7cqlbM4Z15uB2FEbDD6OQSE1qKwMNSq3JTCkyD81Ce3dKZv2gwsWmtyNLY8m0g8HLWyQfjJN6Rb56Cx5XEt393a_tkCB0LldX5BtYCa1U0q83I_6duTc5syC24hsJJfVGgsy3hwJPyZTUQYp4Q75gqHWyQ_v4jSf7fbfW0EtBFmBX6N1W5r1FuBmMDI8Jfi-iZ0tQDl8-rMfR5dnHRX0eX3z-NKunF7HgSe5jIRIsUuTY5TRPWYcZb8PHcwogBIcKqmxZFDl0bV7xNsMqFRkrsUXKyraiGT-O3u76DtZ8H9H5ppdOoFKg0Yyu4ZTzkAVKq4C-eYRem9HqYBeorExKzlIWqNcP1Nj22DWDlT3YdbOPRACSHSCscc7i8g_CaLPJXbPLXRNy12xz16ShiO-KXID1Cu3f2f-p-g0Xp-Tw |
| Cites_doi | 10.1016/j.ejps.2018.07.004 10.1128/mSphere.00098-17 10.1007/s40262-023-01311-w 10.1128/msphere.00274-17 10.1007/s40262-023-01305-8 10.1097/ftd.0000000000000632 10.3390/antibiotics12101478 10.1007/s40262-012-0018-5 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024 Copyright Springer Nature B.V. May 2024 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024 – notice: Copyright Springer Nature B.V. May 2024 |
| DBID | AAYXX CITATION NPM 3V. 4T- 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s40262-024-01357-4 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Docstoc Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Docstoc Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1179-1926 |
| EndPage | 733 |
| ExternalDocumentID | 38573478 10_1007_s40262_024_01357_4 |
| Genre | Letter Comment General Information Commentary Correspondence |
| GroupedDBID | --- -5G -BR -EM .GJ .XZ 0R~ 0VX 199 29B 2JY 34G 36B 39C 3V. 4.4 406 53G 5GY 5RE 6I2 6J9 6PF 7X7 88E 8FI 8FJ 8R4 8R5 8UJ 95. AAAUJ AABHQ AACDK AADNT AAIAL AAIKX AAJKR AAKAS AANZL AARHV AASML AATNV AAWTL AAYQN AAYTO AAYZH ABAKF ABDZT ABFTV ABIPD ABJNI ABJOX ABKCH ABKMS ABKTR ABOCM ABPLI ABTKH ABTMW ABUWG ABWHX ABXPI ACAOD ACCOQ ACCUX ACDTI ACGFO ACGFS ACMJI ACMLO ACOKC ACPIV ACREN ACZOJ ADBBV ADFRT ADFZG ADHHG ADJJI ADQRH ADRFC ADURQ ADYOE ADZCM ADZKW AEBTG AEFQL AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AEYRQ AFALF AFBBN AFFNX AFKRA AFWTZ AFZKB AGAYW AGDGC AGQEE AGQMX AGRTI AHIZS AHMBA AHSBF AIAKS AIGIU AILAN AIZAD AJRNO ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF ASPBG AVWKF AWSVR AXYYD AZFZN A~4 BENPR BGNMA BPHCQ BVXVI BYPQX CAG CCPQU COF CS3 DCUDU DNIVK DPUIP DU5 EBLON EBS EJD EMOBN ESX F5P F8P FERAY FIGPU FLLZZ FNLPD FSGXE FYUFA HF~ HMCUK IAO IEA IHR IMOTQ INH INR ITC IWAJR J-C JZLTJ LGEZI LLZTM LOTEE M1P M4Y NADUK NQJWS NU0 NXXTH OAC OPC OVD P2P PQQKQ PROAC PSQYO Q2X ROL RSV RZALA SISQX SJYHP SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW TEORI TSG U5U U9L UAX UG4 UKHRP UNMZH UTJUX VDBLX VFIZW W48 WAF YQY Z0Y Z7U ZGI ZMTXR ZXP ~JE AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY NPM 4T- 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c326t-cc2e74e3ed60641de53b34730aacc3a9a95f776adb693b5e94c518ebe018b9053 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001197073500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0312-5963 1179-1926 |
| IngestDate | Fri Sep 05 07:02:44 EDT 2025 Fri Nov 07 23:34:46 EST 2025 Wed Feb 19 02:08:11 EST 2025 Sat Nov 29 02:48:35 EST 2025 Fri Feb 21 02:40:27 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-cc2e74e3ed60641de53b34730aacc3a9a95f776adb693b5e94c518ebe018b9053 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Correspondence-1 ObjectType-Commentary-2 content type line 23 |
| ORCID | 0009-0008-6612-044X 0000-0002-2114-587X 0000-0001-6703-0288 |
| PMID | 38573478 |
| PQID | 3058283141 |
| PQPubID | 32335 |
| PageCount | 3 |
| ParticipantIDs | proquest_miscellaneous_3033007009 proquest_journals_3058283141 pubmed_primary_38573478 crossref_primary_10_1007_s40262_024_01357_4 springer_journals_10_1007_s40262_024_01357_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-05-01 |
| PublicationDateYYYYMMDD | 2024-05-01 |
| PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Switzerland – name: Auckland |
| PublicationTitle | Clinical pharmacokinetics |
| PublicationTitleAbbrev | Clin Pharmacokinet |
| PublicationTitleAlternate | Clin Pharmacokinet |
| PublicationYear | 2024 |
| Publisher | Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
| References | Jansen, Ter Heine, Verweij, Bruggemann (CR2) 2023; 62 Roberts, Pea, Lipman (CR4) 2012; 52 Ruvimbo, Stokes, Campbell, Plaxco, Stocker (CR11) 2023; 12 Jansen, Mertens, Spriet, Verweij, Schouten (CR1) 2023; 62 CR3 Jørgensen, Andersen, Astvad, Arendrup (CR8) 2017 Pea, Krause, Carsten, Hennart, Richardson (CR9) 2019; 41 CR6 Nation, Theuretzbacher, Tsuji (CR5) 2018; 122 Wiedman, Zhao, Mustaev, Ping, Vishnubhotla (CR10) 2017 CR7 DM Ruvimbo (1357_CR11) 2023; 12 1357_CR3 RL Nation (1357_CR5) 2018; 122 AME Jansen (1357_CR1) 2023; 62 1357_CR7 1357_CR6 R Jørgensen (1357_CR8) 2017 F Pea (1357_CR9) 2019; 41 GR Wiedman (1357_CR10) 2017 AME Jansen (1357_CR2) 2023; 62 JA Roberts (1357_CR4) 2012; 52 37819503 - Clin Pharmacokinet. 2023 Dec;62(12):1701-1711 37819504 - Clin Pharmacokinet. 2023 Dec;62(12):1695-1699 |
| References_xml | – volume: 122 start-page: 341 year: 2018 end-page: 346 ident: CR5 article-title: Concentration-dependent plasma protein binding: expect the unexpected publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2018.07.004 – year: 2017 ident: CR8 article-title: Implementation of isavuconazole in a fluorescence-based high-performance liquid chromatography kit allowing simultaneous detection of all four currently licensed mold-active triazoles publication-title: mSphere. doi: 10.1128/mSphere.00098-17 – volume: 62 start-page: 1695 issue: 12 year: 2023 end-page: 1699 ident: CR2 article-title: High variability in isavuconazole unbound fraction in clinical practice: a call to reconsider pharmacokinetic/pharmacodynamic targets and breakpoints publication-title: Clin Pharmacokinet doi: 10.1007/s40262-023-01311-w – ident: CR6 – year: 2017 ident: CR10 article-title: An aptamer-based biosensor for the azole class of antifungal drugs publication-title: mSphere. doi: 10.1128/msphere.00274-17 – ident: CR7 – volume: 62 start-page: 1701 issue: 12 year: 2023 end-page: 1711 ident: CR1 article-title: Population pharmacokinetics of total and unbound isavuconazole in critically ill patients: implications for adaptive dosing strategies publication-title: Clin Pharmacokinet doi: 10.1007/s40262-023-01305-8 – ident: CR3 – volume: 41 start-page: 657 issue: 5 year: 2019 end-page: 664 ident: CR9 article-title: Interlaboratory analysis of isavuconazole plasma concentration assays among european laboratories publication-title: Ther Drug Monitor. doi: 10.1097/ftd.0000000000000632 – volume: 12 start-page: 1478 issue: 10 year: 2023 end-page: 1478 ident: CR11 article-title: Real-time monitoring of antibiotics in the critically ill using biosensors publication-title: Antibiotics doi: 10.3390/antibiotics12101478 – volume: 52 start-page: 1 issue: 1 year: 2012 end-page: 8 ident: CR4 article-title: The clinical relevance of plasma protein binding changes publication-title: Clin Pharmacokinet doi: 10.1007/s40262-012-0018-5 – volume: 52 start-page: 1 issue: 1 year: 2012 ident: 1357_CR4 publication-title: Clin Pharmacokinet doi: 10.1007/s40262-012-0018-5 – volume: 12 start-page: 1478 issue: 10 year: 2023 ident: 1357_CR11 publication-title: Antibiotics doi: 10.3390/antibiotics12101478 – volume: 62 start-page: 1695 issue: 12 year: 2023 ident: 1357_CR2 publication-title: Clin Pharmacokinet doi: 10.1007/s40262-023-01311-w – volume: 41 start-page: 657 issue: 5 year: 2019 ident: 1357_CR9 publication-title: Ther Drug Monitor. doi: 10.1097/ftd.0000000000000632 – volume: 62 start-page: 1701 issue: 12 year: 2023 ident: 1357_CR1 publication-title: Clin Pharmacokinet doi: 10.1007/s40262-023-01305-8 – year: 2017 ident: 1357_CR10 publication-title: mSphere. doi: 10.1128/msphere.00274-17 – ident: 1357_CR3 – volume: 122 start-page: 341 year: 2018 ident: 1357_CR5 publication-title: Eur J Pharm Sci doi: 10.1016/j.ejps.2018.07.004 – ident: 1357_CR6 – year: 2017 ident: 1357_CR8 publication-title: mSphere. doi: 10.1128/mSphere.00098-17 – ident: 1357_CR7 – reference: 37819504 - Clin Pharmacokinet. 2023 Dec;62(12):1695-1699 – reference: 37819503 - Clin Pharmacokinet. 2023 Dec;62(12):1701-1711 |
| SSID | ssj0008200 |
| Score | 2.4365869 |
| Snippet | Currently, there is no evidence that unbound isavuconazole concentrations are a better predictor of treatment response than total concentrations. [...]clinical... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 731 |
| SubjectTerms | Antibiotics Biomarkers Biosensors Clinical medicine Conflicts of interest Drug dosages Internal Medicine Laboratories Letter to the Editor Medicine Medicine & Public Health Pharmaceutical industry Pharmacodynamics Pharmacokinetics Pharmacology/Toxicology Pharmacotherapy Proteins Real time |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEDawcODC-xFY0FChvVCrTe08vBdUFip6WeXQRb1FjuNI1Za4NO1K4dczdh5lWcGFY5Q4Hkuf52HPfEPI-1BxhnZMUi1DTTmPJEUdWNBcSB2ih8_9uHDNJqLz83i5FEl74Fa1aZWdTnSKOjfKnpGPEJc4lPnc_7j5QW3XKHu72rbQuEPu2rbZljs_WvYBl7Vu46ZQBwMuRFpbNONK5zBuCicULRQG0yyIKL9umG54mzduSp0Bmj38X9EfkQet6wnTBiuPyW1dPiEnScNdXQ9hcSjFqoZwAsmB1bp-emtkS0nQQoEpYZD0bb_6ry7RXbUjwRSwMOjSgyxzuCgz27cJ5pW82mPoLX-atYZVCV2LhXUN8_UakobetTqF-W8p7oAeNUxzubE6GT4be64BHZ-urgZuioFNVYFvGPM3lOO1_f31-TopZtumjMMJ0JaEQtLWiZ3CFM5QINgZsEF508j0z_WNuue8LuX3lYKFS6WvnCif0AO_3JgVLmTwjFzMvizOvtK22wRV6MLuqFITHXHNdI4xHfdzHbCMcVSAUirFpJAiKKIolHkWCpYFWnAV-DHugbEfZwJ12XNyVJpSvyQQijHTcTjOOJdciSLTQmeRzqQ9tIviwCMfOqilm4ZUJO3pox0wUwRm6oCZco8cd7BKWwVTpQdMeeRd_xpVg73vkaU2e_sNY5bOaSw88qJBcT8di4MIVxd7ZNjB-vDzv8vy6t-yvCb3J25L2YTQY3K02-71G3JPXe1W1fat25y_AJQ1Rag priority: 102 providerName: ProQuest |
| Title | Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints” |
| URI | https://link.springer.com/article/10.1007/s40262-024-01357-4 https://www.ncbi.nlm.nih.gov/pubmed/38573478 https://www.proquest.com/docview/3058283141 https://www.proquest.com/docview/3033007009 |
| Volume | 63 |
| WOSCitedRecordID | wos001197073500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1179-1926 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0008200 issn: 0312-5963 databaseCode: 7X7 dateStart: 20070601 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1179-1926 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0008200 issn: 0312-5963 databaseCode: BENPR dateStart: 20070601 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1179-1926 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008200 issn: 0312-5963 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5oixAXHgVKoESDhHohFnZ27fX2lpZG5EBklbTKzVrbaylqakdxUsmc-kPgz_WXMLt-hFI4wMVS5M3urPTtPLzzzRDy3osZRTsmLSU9ZTHGpYU6MLUSIZWHHj5z_NQ0m-DjsT-diqAmhRVNtntzJWk0dUt2w0jH61toUzD8pS632BbZQXPn6-N4-vW81b9o0-yKnoNhFuKrpsr8eY7b5uiOj3nnftSYneGT_xP4KXlcu5kwqHDxjNxX2S55-KW-SN8lB0FVsrrswWTDwCp6cADBpph1-fwe1wwSNEyQZ3Bz_T1o-3214y5wQv1fyFOY5OjLg8wSOMsi3bAJRoW8WmPMLb_lcwWzDJreCvMSRvM5BFVd1-IQRr_ktgO60jBI5EIrY_iU6w8a0BTSVcXN9Q-zCAqk81TgHAP-qt54qZe4vWYjyXBZcTiMEDUfFIKaJHYIAzhGoWCVg47Iqy6mv-_xY_M7KTN5OYthYvLoCyPMEbrfF4t8hptB-V6Qs-HJ5PizVTebsGL0YFdWHPcVZ4qqBEM65iTKpRFlqP-kjGMqhRRuyrknk8gTNHKVYLHr-HgEbMePBKqyl2Q7yzP1ioAnbKp8z44YkywWaaSEiriKpP5mx323Qz40mAsXVU2RsK0ebUATImhCA5qQdch-A8uw1i9FiFoaDxJ1mNMh79rXqBn0dY_MVL7WYyjV1Zxs0SF7FZzb5ajvctyd3yG9Brubyf8uy-t_G_6GPOob-Ov80H2yvVqu1VvyIL5azYpll2zxKTdPv0t2jk7GwWnXnOSfptNJ2w |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFDfTQIIL37DCgEcFu9CoSe3EySSEyka1aqPKoUO9BcdxpWpdUpp2KPxR_I08Ox9lTHDbgWOUOH5O3qf9fu8R8saTjKIdE5YSnrIY48JCHTi1kkAoDz185vhT02yCj0b-ZBKEW-RnjYXRaZW1TjSKOsmk3iPvIl_iUOow58Pim6W7RunT1bqFRskWx6r4jiFb_n54iP_3ba83-DQ-OLKqrgKWRFdlZUnZU5wpqhL03ZmTKJfGlCGjCyElFYEI3CnnnkhiL6CxqwImXcfHtdqOHwe27hKBKv8m6nGuU8j4pAnwtDW1S2AQBnjI2RVIx0D1ME7zehZaRAzeqcstdtkQXvFur5zMGoM3uPe_far75G7lWkO_lIUHZEulD8leWNbmLjow3kDN8g7sQbip2l08utHVUBm0wJCl0A6btmbNU2fojuuRkE1hnGHIAiJN4DSNdV8qGObiYi0xqvmRzRXMUqhbSMwLGM7nEJbla_N9GP6Wwg8YMUA_EQttc-Aw0_s2UNcLVnnbTNHWqTjwRaCmMInMhX795flqKgbLEqZiCKggrxBWOLh96MMBEgSrDPSmQ9mo9c_1devrpEjF-UzC2EAFckPKR4wwzhbZDBfSfkxOr-VnPiHbaZaqHQJeYFPle3bMmGAymMYqUDFXsdCbktx3W-RdzdrRoiyaEjXlsY0gRCgIkRGEiLXIbs3GUaVA82jDwy3yurmNqk-fZ4lUZWv9DKW6XJUdtMjTUmqa6ajvclyd3yKdWow2L_87Lc_-Tcsrcvto_PkkOhmOjp-TOz0jzjr5dZdsr5Zr9YLckherWb58aRQDkK_XLV6_AM1do2Q |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6qghAX3o9AgSGCXhordnbttSshFFoioqLIhxTlZtbrtRQ12CFOisxP49cxu36EUsGtB46Wvd5Ze567880Q8tqTjKIdE5YSnrIY48JCHZhaSSCUhx4-c_zUNJvgk4k_mwXhDvnZYGF0WmWjE42iTnKp98j7yJc4lDrM6ad1WkR4PHq3_GbpDlL6pLVpp1GxyIkqv2P4VrwdH-O_fjMYjD5Mjz5adYcBS6LbsrakHCjOFFUJ-vHMSZRLY8qQ6YWQkopABG7KuSeS2Ato7KqASdfxcd2248eBrTtGoPq_zinlum0En7XBnrasdgUSwmAPubwG7BjYHsZs3sBC64iBPHW5xS4axUue7qVTWmP8Rnf-5892l9yuXW4YVjJyj-yo7D7ZD6ua3WUPplsIWtGDfQi31bzLB9f6GkKDlhnyDLph2-6sfeoM3XQ9EvIUpjmGMiCyBE6zWPergnEhzjcSo50f-ULBPIOmtcSihPFiAWFV1rY4hPFvqf2AkQQME7HUtgiOc72fA00dYVV0zRRdnaIDnwVqEJPgXOrXX5yvoWK0quArhoAaCgthjY87hCEcIUGwzkFvRlQNXP9cX7-5TspMfJ1LmBoIQWFIeY-Rx9kyn-NCug_J6ZX8zEdkN8sz9YSAF9hU-Z4dMyaYDNJYBSrmKhZ6s5L7boccNGweLatiKlFbNtsIRYRCERmhiFiH7DUsHdWKtYi2_Nwhr9rbqBL1OZfIVL7Rz1Cqy1jZQYc8riSonY76LsfV-R3Sa0Rq-_K_0_L037S8JDdRqqJP48nJM3JrYCRb58Tukd31aqOekxvyfD0vVi-MjgDy5aql6xdnm6wY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comment+on+%22Population+Pharmacokinetics+of+Total+and+Unbound+Isavuconazole+in+Critically+Ill+Patients%3A+Implications+for+Adaptive+Dosing+Strategies%22+and+%22High+Variability+in+Isavuconazole+Unbound+Fraction+in+Clinical+Practice%3A+A+Call+to+Reconsider+Pharmacokinetic%2FPharmacodynamic+Targets+and+Breakpoints%22&rft.jtitle=Clinical+pharmacokinetics&rft.au=Kong%2C+Leping&rft.au=Alffenaar%2C+Jan-Willem+C&rft.au=Stocker%2C+Sophie+L&rft.date=2024-05-01&rft.issn=1179-1926&rft.eissn=1179-1926&rft.volume=63&rft.issue=5&rft.spage=731&rft_id=info:doi/10.1007%2Fs40262-024-01357-4&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0312-5963&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0312-5963&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0312-5963&client=summon |